{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:26:16Z","timestamp":1792664776574,"version":"4.5.0"},"reference-count":23,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Translational Sci"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Nirmatrelvir boosted with ritonavir is a key antiviral against COVID\u201019, yet ritonavir's potent CYP3A4 inhibition exposes patients to numerous drug\u2013drug interactions. To make prescribing safer, a national proactive system providing expert pharmacology advice was implemented in France. This retrospective study reports the experience of the pharmacology department at Rennes University Hospital, which provided these expert services from February 2022 to December 2024. We evaluated 455 consecutive patients (median age 75\u2009years, median eight co\u2010medications per patient, 3813 prescription lines). Nirmatrelvir\/ritonavir was ultimately contra indicated in 26 patients. Among the 429 eligible patients (3582 prescription lines), 86.7% (372\/429) had at least one clinically relevant drug interaction; 60.8% (261\/429) had \u2265\u20092; 30.4% (130\/429) had \u2265\u20093. Among the 831 interacting medication lines, the main drug classes involved: statins (17.7%, 147\/831), immunosuppressants (12.0%, 100\/831), and direct oral anticoagulants (10.5%, 87\/831), with the drug mix evolving over time from transplant\u2010related immunosuppressants in 2022 to statin agents in 2023\u20132024. Expert review identified options to navigate initial contraindications in 13.5% (58\/429) of patients. Despite a very high prevalence of potential clinically relevant DDIs, the service supported prescribers\u2019 decision\u2010making to consider nirmatrelvir\/ritonavir in most evaluated patients, primarily via conservative co\u2010medication management: continue unchanged 77.2% (2764\/3582), temporary interruption 13.8% (493\/3582), dose adjustment 5.8% (208\/3582), alternative therapy (117\/3582); and via targeted monitoring: clinical monitoring 45.9% (197\/429) and therapeutic drug monitoring 14.2% (61\/429). As a retrospective service evaluation, these findings are hypothesis\u2010generating and emphasize a scalable model of proactive clinical pharmacology support to secure interaction\u2010prone therapies in aging, polymedicated populations.<\/jats:p>","DOI":"10.1111\/cts.70443","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T11:43:18Z","timestamp":1772970198000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Managing High\u2010Risk Drug Interactions With Nirmatrelvir\/Ritonavir: Experience From a Dedicated Pharmacology Advice Service"],"prefix":"10.1111","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6134-2130","authenticated-orcid":false,"given":"Youssef","family":"Libiad","sequence":"first","affiliation":[{"name":"Univ Rennes, Service de Pharmacologie Biologique, CHU Rennes, EHESP, Irset (Institut de Recherche en sant\u00e9, Environnement et Travail) \u2013 UMR S 1085  Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Franck","sequence":"additional","affiliation":[{"name":"Univ Rennes, Service de Pharmacologie Biologique, CHU Rennes, EHESP, Irset (Institut de Recherche en sant\u00e9, Environnement et Travail) \u2013 UMR S 1085  Rennes France"},{"name":"INSERM, Centre D'investigation Clinique 1414  Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Tron","sequence":"additional","affiliation":[{"name":"Univ Rennes, Service de Pharmacologie Biologique, CHU Rennes, EHESP, Irset (Institut de Recherche en sant\u00e9, Environnement et Travail) \u2013 UMR S 1085  Rennes France"},{"name":"INSERM, Centre D'investigation Clinique 1414  Rennes France"},{"name":"FHU SUPORT  Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Lalanne","sequence":"additional","affiliation":[{"name":"Univ Rennes, Service de Pharmacologie Biologique, CHU Rennes, EHESP, Irset (Institut de Recherche en sant\u00e9, Environnement et Travail) \u2013 UMR S 1085  Rennes France"},{"name":"INSERM, Centre D'investigation Clinique 1414  Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Boglione\u2010Kerrien","sequence":"additional","affiliation":[{"name":"Univ Rennes, Service de Pharmacologie Biologique, CHU Rennes, EHESP, Irset (Institut de Recherche en sant\u00e9, Environnement et Travail) \u2013 UMR S 1085  Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Ta\u00efeb","sequence":"additional","affiliation":[{"name":"Univ Rennes, Service de Pharmacologie Biologique, CHU Rennes, EHESP, Irset (Institut de Recherche en sant\u00e9, Environnement et Travail) \u2013 UMR S 1085  Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6595-8154","authenticated-orcid":false,"given":"Marie\u2010Cl\u00e9mence","family":"Verdier","sequence":"additional","affiliation":[{"name":"Univ Rennes, Service de Pharmacologie Biologique, CHU Rennes, EHESP, Irset (Institut de Recherche en sant\u00e9, Environnement et Travail) \u2013 UMR S 1085  Rennes France"},{"name":"INSERM, Centre D'investigation Clinique 1414  Rennes France"},{"name":"FHU SUPORT  Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0908-3629","authenticated-orcid":false,"given":"Florian","family":"Lemaitre","sequence":"additional","affiliation":[{"name":"Univ Rennes, Service de Pharmacologie Biologique, CHU Rennes, EHESP, Irset (Institut de Recherche en sant\u00e9, Environnement et Travail) \u2013 UMR S 1085  Rennes France"},{"name":"INSERM, Centre D'investigation Clinique 1414  Rennes France"},{"name":"FHU SUPORT  Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"European Medicines Agency \u201cNirmatrelvir\/Ritonavir Informations \u201dhttps:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/paxlovid."},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114636"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118542"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01586-0"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00118-4"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02156-9"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2022.03.005"},{"key":"e_1_2_8_9_1","unstructured":"Direction g\u00e9n\u00e9rale de la sant\u00e9 \u201cSupport Device for Prescription of Paxlovid \u201d(2022) https:\/\/sante.gouv.fr\/IMG\/pdf\/dgs\u2010urgent%20no2022%2080%20\u2010%20dispositif%20d'appui%20%C3%A0%20la%20prescription%20de%20paxlovid.pdf."},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0293302"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1R621"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-023-00832-3"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-01050-w"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2023.03.001"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-022-01158-7"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2024.12360"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000001014"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.42140"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2024.07.003"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2805"},{"key":"e_1_2_8_21_1","unstructured":"FDA \u201cAntimicrobial Drugs Advisory Committee Meeting (16 March 2023) \u201d(2023) https:\/\/www.fda.gov\/media\/166237\/download."},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-017-2232-4"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15341"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/14604582241263242"}],"container-title":["Clinical and Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cts.70443","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cts.70443","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cts.70443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:37:51Z","timestamp":1774010271000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1111\/cts.70443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1111\/cts.70443"],"URL":"https:\/\/doi.org\/10.1111\/cts.70443","archive":["Portico"],"relation":{},"ISSN":["1752-8054","1752-8062"],"issn-type":[{"value":"1752-8054","type":"print"},{"value":"1752-8062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"2025-07-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70443"}}